165 related articles for article (PubMed ID: 3520085)
21. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
22. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
Distler A; Kirch W; Lüth B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
[TBL] [Abstract][Full Text] [Related]
24. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
25. [Minimal useful dose of guanfacine in patients with essential hypertension].
Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
[No Abstract] [Full Text] [Related]
26. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
Jerie P
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
[No Abstract] [Full Text] [Related]
27. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
[TBL] [Abstract][Full Text] [Related]
28. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
Bazika V; Neuzil P; Tiserová J; Hrabovský F
Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
[No Abstract] [Full Text] [Related]
29. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
30. Comparison of guanfacine and clonidine as antihypertensive agents.
Jäättelä A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
[TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
[TBL] [Abstract][Full Text] [Related]
32. [Circadian changes in arterial blood pressure and hemodynamics and the morphofunctional state of the myocardium in patients with hypertension during long-term treatment with estulic].
Komarov FI; Ol'binskaia LI; Iamshchikov SN
Klin Med (Mosk); 1990 Feb; 68(2):58-61. PubMed ID: 2186218
[TBL] [Abstract][Full Text] [Related]
33. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
MacCarthy P; Isaac P; Frost G; Freeman A; Stokes G
Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamics in hypertensive patients before and during guanfacine treatment.
Schäfer N; Rauh J; Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
Dupont AG; Vanderniepen P; Six RO
Bibl Cardiol; 1987; (42):161-7. PubMed ID: 3307757
[No Abstract] [Full Text] [Related]
36. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
37. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study.
Hauger-Klevene JH; Pinkas MB; Gerber S
Hypertension; 1981; 3(6 Pt 2):II-222-5. PubMed ID: 7028619
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
40. Concentration-dependent blood pressure effects of guanfacine.
Frisk-Holmberg M; Wibell L
Clin Pharmacol Ther; 1986 Feb; 39(2):169-72. PubMed ID: 2867846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]